Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Energis Solutions is a U.S. biotechnology and food-safety company developing pathogen-reduction technologies for agricultural and industrial applications. Its products are based on patented equipment that generates an on-demand, highly energized water-based fluid formulated around stabilized chlorine dioxide for use in meat processing, wheat tempering, and other decontamination settings. The company has promoted two principal systems, Guardian for flour milling and grain applications and Voltai for meat protein processing, with reported third-party validation studies and regulatory submissions for certain uses. Energis appears to operate as an independent company following separation from the PHM Brands portfolio, while still retaining roots in technologies originally developed for defense-equipment decontamination. Overall, it is better characterized as a commercial food-safety/ag-biotech platform company than as a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Energis Solutions.